OrthoPediatrics

OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. It offers products relating to trauma and deformity, scoliosis, and sports medicine and other procedures. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

OrthoPediatrics achieves record revenue growth and eyes international expansion

OrthoPediatrics delivered strong financial performance in 2022, achieving profitability and record revenue growth despite challenges. With a focus on new product launches, international expansion, and surgeon training, the company is well-positioned for continued growth and profitability.

OrthoPediatrics reports robust Q1 earnings, eyes international growth opportunities

OrthoPediatrics had a strong Q1 2023, with increased revenue guidance for the full year. The company remains cautiously optimistic due to staffing dynamics. Focus on new product development, acquisitions, and addressing digital needs of children's hospitals highlight growth strategies.

OrthoPediatrics achieves record Q2 performance amidst growth challenges

OrthoPediatrics delivered strong Q2 results with record child assistance and revenue growth, driven by trauma, deformity, and international segments.
While facing challenges like atypical growth patterns and delays in product launches, the company is well-positioned to capitalize on opportunities in enabling technologies and international expansion.
The focus on long-term growth drivers and strategic acquisitions underscores OrthoPediatrics' commitment to sustainable growth and innovation in pediatric orthopedics.
Overall, OrthoPediatrics' performance highlights operational efficiency, market demand, and a clear path for future growth and expansion.

OrthoPediatrics achieves record revenue in Q3 2023, eyes continued growth

OrthoPediatrics reported strong financial performance in Q3 2023, with record revenue and EBITDA, positioning the company for future growth. Despite challenges in certain segments, opportunities in new product launches, international expansion, and surgeon training initiatives offer avenues for continued success. The company's positive outlook and robust pipeline indicate a promising trajectory for OrthoPediatrics.

OrthoPediatrics achieves record revenue and EBITDA, eyes international expansion

OrthoPediatrics delivered strong financial performance in 2023, setting revenue and EBITDA records. The company's strategic focus on sustainable growth, profitability, and diversification positions it well for future success.

OrthoPediatrics reports robust Q1 growth, raises full-year revenue guidance

OrthoPediatrics demonstrated strong performance in Q1 2024 with significant growth in patients helped, revenue, and key business segments. While facing challenges such as an EBITDA loss and increased expenses, the company's focus on growth, new product launches, and financial targets positions it well for the future.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

OrthoPediatrics and ApiFix are committed to helping patients with adolescent idiopathic scoliosis and their families make informed decisions about treatment options in partnership with their physiotherapist and pediatric orthopedic specialist OrthoPediatrics and ApiFix are committed to helping patients with adolescent idiopathic scoliosis and their families make informed decisions about treatment options in partnership with their physiotherapist and pediatric orthopedic specialist

OrthoPediatrics Corp. Launches Dedicated ApiFix Website to Support Game-Changing Spinal Deformity Correction System for Treating AIS

NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating claims of violations of federal securities laws on behalf of investors of OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS).

SHAREHOLDER ALERT: Lowey Dannenberg, P.C., Investigates Claims on Behalf of Investors of OrthoPediatrics Corp. (KIDS) and Encourages Investors to Contact the Firm

New York, New York--(Newsfile Corp. - February 15, 2021) - Pomerantz LLP is investigating claims on behalf of investors of OrthoPediatrics Corporation ("OrthoPediatrics" or the "Company") (NASDAQ: KIDS). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether OrthoPediatrics and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OrthoPediatrics Corporation - KIDS

NEW YORK, Feb. 15, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of OrthoPediatrics Corp. (NASDAQ: KIDS) resulting from allegations that OrthoPediatrics may have issued materially misleading business information to the investing public.

BREAKING ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages OrthoPediatrics Corp. Investors to Inquire About Class Action Investigation – KIDS

Los Angeles, California--(Newsfile Corp. - February 8, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of OrthoPediatrics Corp. (NASDAQ: KIDS) ("OrthoPediatrics" or "the Company") for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. OrthoPediatrics is the subject of a report published by Culper Research...

ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against OrthoPediatrics Corp. and Encourages Investors with Losses of $100,000 to Contact the Firm

NEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of OrthoPediatrics Corp. (NASDAQ: KIDS) resulting from allegations that OrthoPediatrics may have issued materially misleading business information to the investing public.

BREAKING NEWS: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages OrthoPediatrics Corp. Investors with Losses to Inquire About Class Action Investigation – KIDS

LOS ANGELES, Feb. 1, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of OrthoPediatrics Corp. ("OrthoPediatrics" or "the Company") (NASDAQ: KIDS) for violations of the securities laws....

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against OrthoPediatrics Corp. and Encourages Investors with Losses of $100,000 to Contact the Firm

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In OrthoPediatrics Corporation To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - January 28, 2021) - Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating potential violations of the federal securities laws against OrthoPediatrics Corporation ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS).If you suffered losses exceeding $50,000 investing in OrthoPediatrics Corporation securities and would like to discuss your legal rights, click here: www.faruqilaw.com/KIDS or call Faruqi & Faruqi partner James Wilson directly at 877-247-4292 or 212-983-9330...

Orthopediatrics Corporation Investor Alert

WARSAW, Ind., Jan. 22, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, continues to expand their product offering in Australia and New Zealand. Within the past 12 months we have launched the Pediatric Nailing Platform (PNP), Response 4.5/5.0 Spine System and most recently, the Orthex system.

OrthoPediatrics Corp. Introduces Orthex in Australia

New York, New York--(Newsfile Corp. - January 21, 2021) - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of OrthoPediatrics Corp. (NASDAQ: KIDS) resulting from allegations that OrthoPediatrics may have issued materially misleading business information to the investing public.On December 2, 2020, Culper Research published a report entitled "OrthoPediatrics Corp. (KIDS): Even Channel Stuffing Can't Save This Company[.]" The report alleged that OrthoPediatrics has...

Rosen, A Longstanding and Trusted Law Firm, Continues to Investigate Securities Claims Against OrthoPediatrics Corp. - KIDS

WARSAW, Ind., Jan. 19, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, has obtained 14 product registrations in Canada over the past 12 months. This list includes three newly introduced Trauma & Deformity Correction products (Orthex, PNP|FEMUR and PediFoot) and features the RESPONSE Scoliosis family, which is comprised of RESPONSE 4.5/5.0 and 5.5/6.0 Systems and BandLoc, a pedicle-sparing, sublaminar banding technology.

OrthoPediatrics Corp. Introduces Expanded Product Portfolio in Canada

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of OrthoPediatrics Corp. (NASDAQ: KIDS) resulting from allegations that OrthoPediatrics may have issued materially misleading business information to the investing public. On December 2, 2020, Culper Research published a report entitled “OrthoPediatrics Corp. (KIDS): Even Channel Stuffing Can't Save This Company[.]” The report alleged that

ROSEN, RESPECTED INVESTOR COUNSEL Continues to Investigate Securities Claims Against OrthoPediatrics Corp. – KIDS

WARSAW, Ind., Jan. 15, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its agent network in Germany, Austria and Switzerland.

OrthoPediatrics Corp. Expands its Agent Network in Three Strategic European Countries

San Francisco, California--(Newsfile Corp. - January 14, 2021) - Hagens Berman urges OrthoPediatrics Corp. (NASDAQ: KIDS) investors to submit their losses now. Visit: www.hbsslaw.com/investor-fraud/KIDS Contact An Attorney Now: KIDS@hbsslaw.com 844-916-0895OrthoPediatrics Corp. (KIDS) Investigation:The investigation concerns whether OrthoPediatrics artificially inflated revenues and overstated inventory.In past quarters, OrthoPediatrics touted its "consistent 20% plus growth rate," which in turn has allowed the Company to maintain a valuat

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst's Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now

NEW YORK, Jan. 14, 2021 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of OrthoPediatrics Corp. (NASDAQ: KIDS) resulting from allegations that OrthoPediatrics may have issued materially...

ROSEN, A TOP RANKED LAW FIRM, Continues to Investigate Securities Claims Against OrthoPediatrics Corp. - KIDS

Full year revenue up 2%, representing strong execution in an unprecedented global environment Full year revenue up 2%, representing strong execution in an unprecedented global environment

OrthoPediatrics Corp. Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2020

BENSALEM, Pa.--(BUSINESS WIRE)---- $KIDS #CLASSACTION--INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of OrthoPediatrics Corp. (KIDS) on Behalf of Investors

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of OrthoPediatrics Corp. (KIDS) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $KIDS #CLASSACTION--Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of OrthoPediatrics Corp. (KIDS) on Behalf of Investors

Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of OrthoPediatrics Corp. (KIDS) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $KIDS #investors--The Law Offices of Frank R. Cruz Continues its Investigation of OrthoPediatrics Corp. (KIDS) on Behalf of Investors

The Law Offices of Frank R. Cruz Continues its Investigation of OrthoPediatrics Corp. (KIDS) on Behalf of Investors

NEW YORK--(BUSINESS WIRE)-- #Investigation--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against OrthoPediatrics Corp. (NASDAQ: KIDS) on behalf of OrthoPediatrics stockholders. Our investigation concerns whether OrthoPediatrics has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On December 2, 2020, Culper Research (“Culper”) published a report entitled “O

ORTHOPEDIATRICS ALERT: Bragar Eagel & Squire, P.C. Is Investigating OrthoPediatrics Corp. on Behalf of OrthoPediatrics Stockholders and Encourages Investors to Contact the Firm

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In OrthoPediatrics Corporation To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - January 5, 2021) -  Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating potential violations of the federal securities laws against OrthoPediatrics Corporation ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS).If you suffered losses exceeding $50,000 investing in OrthoPediatrics Corporation securities and would like to discuss your legal rights, click here: www.faruqilaw.com/KIDS or call Faruqi & Faruqi partner James Wilson directly at 877-247-4292 or 212-983-9330...

OrthoPediatrics Corporation Shareholder Alert

BENSALEM, Pa.--(BUSINESS WIRE)---- $KIDS #CLASSACTION--INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of OrthoPediatrics Corp. (KIDS) on Behalf of Investors

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of OrthoPediatrics Corp. (KIDS) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $KIDS #investors--The Law Offices of Frank R. Cruz Announces Investigation of OrthoPediatrics Corp. (KIDS) on Behalf of Investors

The Law Offices of Frank R. Cruz Announces Investigation of OrthoPediatrics Corp. (KIDS) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $KIDS #CLASSACTION--Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of OrthoPediatrics Corp. (KIDS) on Behalf of Investors

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of OrthoPediatrics Corp. (KIDS) on Behalf of Investors

New York, New York--(Newsfile Corp. - January 4, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ: KIDS) resulting from allegations that OrthoPediatrics might have issued misleading information to the investing public.If you purchased OrthoPediatrics securities, and/or would like to discuss your legal rights and options please visit KIDS Shareholder Investigation or contact Matthew E....

News for OrthoPediatrics Stock (KIDS)